[LGND] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
31-Oct-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -19.60%
YoY- -34.86%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 18,418 14,602 22,998 14,973 10,608 15,958 14,737 16.07%
PBT 22,292 -74 7,012 901 1,241 2,150 2,008 399.84%
Tax 265 15 279 124 -47 53 139 53.93%
NP 23,564 754 7,055 1,280 1,592 2,097 1,869 444.22%
Tax Rate -1.19% - -3.98% -13.76% 3.79% -2.47% -6.92% -
Total Cost -5,146 13,848 15,943 13,693 9,016 13,861 12,868 -
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 127.94 5.16 30.68 8.55 15.01 13.14 12.68 368.91%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS 1.19 0.04 0.35 0.06 0.08 0.10 0.09 461.81%
EPS Diluted 1.11 0.04 0.34 0.06 0.07 0.10 0.09 436.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.